C B Pratt

3.7k citations

65 papers · 2.6k indexed · h-index 29

Impact in

Oncology top 5%
- Cancer Treatment and Pharmacology
Neurology top 2%
- Neuroblastoma Research and Treatments

Papers in ⓘ

Neurology 14
- Neuroblastoma Research and Treatments 13
Pathology and Forensic Medicine 13
- Chemotherapy-induced organ toxicity mitigation 7

Co-authors: William H. Meyer (11 shared papers)L. Kun (4 shared papers)Sue C. Kaste (9 shared papers)Marc E. Horowitz (6 shared papers)Gaston K. Rivera (5 shared papers)Clinton F. Stewart (5 shared papers)Craig A. Hurwitz (3 shared papers)M L Hancock (3 shared papers)
Journals: Journal of Clinical Oncology (24 papers)American Journal of Roentgenology (3 papers)Cancer (2 papers)Journal of Pediatric Surgery (2 papers)JNCI Journal of the National Cancer Institute (1 paper)
Partner nations: United States Canada Slovakia

In The Last Decade

C B Pratt

65 papers receiving 2.5k citations

Peers

Countries citing papers authored by C B Pratt

Since Specialization

Citations

This map shows the geographic impact of C B Pratt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C B Pratt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C B Pratt more than expected).

Fields of papers citing papers by C B Pratt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C B Pratt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C B Pratt. The network helps show where C B Pratt may publish in the future.

Co-authors

The 25 scholars most cited alongside C B Pratt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with C B Pratt Line = papers co-authored together C B Pratt links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 65 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Second malignancies after Ewing's sarcoma: radiation dose-dependency of secondary sarcomas. Journal of Clinical Oncology ·John F. Kuttesch, Leonard H. Wexler, Robert B. Marcus, Diane L. Fairclough, Linda Weaver‐McClure, Michael A. White, Liang Mao, Thomas F. DeLaney, C B Pratt, Marc E. Horowitz, L. Kun	1996	254
2	Secondary brain tumors in children treated for acute lymphoblastic leukemia at St Jude Children's Research Hospital. Journal of Clinical Oncology ·Andrew W. Walter, M L Hancock, Ching‐Hon Pui, Melissa M. Hudson, J Ochs, Gaston K. Rivera, C B Pratt, James M. Boyett, L. Kun	1998	187
3	Prognostic significance of apoptosis regulators in breast cancer. Endocrine Related Cancer ·Stanisław Krajewski, Maryla Krajewska, Bruce Turner, C B Pratt, Beatrice A. Howard, Juan M. Zapata, (unknown), Susan J. Robertson, Yurij Ionov, Hiroshi Yamamoto, Manuel Perucho, Shinichi Takayama, John C. Reed	1999	150
4	Phase I study of topotecan for pediatric patients with malignant solid tumors. Journal of Clinical Oncology ·C B Pratt, Clinton F. Stewart, Victor M. Santana, Laura C. Bowman, Wayne L. Furman, J Ochs, Neyssa Marina, John F. Kuttesch, Richard L. Heideman, John T. Sandlund	1994	116
5	Saturable pharmacokinetics and paclitaxel pharmacodynamics in children with solid tumors. Journal of Clinical Oncology ·Daryl Sonnichsen, Craig A. Hurwitz, C B Pratt, J J Shuster, Mary V. Relling	1994	116
6	Subsequent malignancies in children and adolescents after treatment for Hodgkin's disease. Journal of Clinical Oncology ·Orren Beaty, Melissa M. Hudson, C Greenwald, Xiaolong Luo, Lei Fang, Judith A. Wilimas, Elizabeth I. Thompson, L. Kun, C B Pratt	1995	112
7	Ifosfamide, Fanconi's syndrome, and rickets. Journal of Clinical Oncology ·C B Pratt, William H. Meyer, Jesse J. Jenkins, Lisa Avery, Charles P. McKay, Robert Wyatt, M L Hancock	1991	103
8	Central nervous system toxicity following the treatment of pediatric patients with ifosfamide/mesna. Journal of Clinical Oncology ·C B Pratt, A A Green, Marc E. Horowitz, William H. Meyer, Erlinda Etcubanas, E C Douglass, F. Ann Hayes, Elizabeth Thompson, Judith A. Wilimas, Masaki Igarashi	1986	91
9	Clinical pharmacodynamics of continuous infusion topotecan in children: systemic exposure predicts hematologic toxicity. Journal of Clinical Oncology ·Clinton F. Stewart, Sharyn D. Baker, Richard L. Heideman, Donald J. L. Jones, W R Crom, C B Pratt	1994	87
10	Ifosfamide plus etoposide in newly diagnosed Ewing's sarcoma of bone. Journal of Clinical Oncology ·William H. Meyer, Larry E. Kun, Neyssa Marina, PK Roberson, David M. Parham, B. N. Rao, Barry D. Fletcher, C B Pratt	1992	79
11	Synovial sarcoma in children and adolescents: the St Jude Children's Research Hospital experience. Journal of Clinical Oncology ·Alberto S. Pappo, James Fontanesi, Xiaolong Luo, B. N. Rao, David M. Parham, Craig A. Hurwitz, Lisa Avery, C B Pratt	1994	74
12	Phase I trial of paclitaxel in children with refractory solid tumors: a Pediatric Oncology Group Study. Journal of Clinical Oncology ·Craig A. Hurwitz, Mary V. Relling, Steven Weitman, Y. Ravindranath, Teresa J. Vietti, Douglas Strother, A H Ragab, C B Pratt	1993	73
13	Conduct of phase I trials in children with cancer. Journal of Clinical Oncology ·Malcolm A. Smith, Mark L. Bernstein, W. Archie Bleyer, J D Borsi, P. S. P. Ho, I J Lewis, A D Pearson, F Pein, C B Pratt, Gregory H. Reaman, Riccardo Riccardi, Nita L. Seibel, Robert C. Trueworthy, Richard S. Ungerleider, Gilles Vassal, Teresa J. Vietti	1998	69
14	Therapeutic effects and pharmacokinetics of recombinant human granulocyte-macrophage colony-stimulating factor in childhood cancer patients receiving myelosuppressive chemotherapy. Journal of Clinical Oncology ·Wayne L. Furman, Diane L. Fairclough, Richard D. Huhn, C B Pratt, Norbert Stute, W P Petros, William E. Evans, Laura C. Bowman, E C Douglass, Victor M. Santana	1991	68
15	Phase II trial of ifosfamide in children with malignant solid tumors. PubMed ·C B Pratt, Marc E. Horowitz, William H. Meyer, Erlinda Etcubanas, Elizabeth I. Thompson, E C Douglass, Judith A. Wilimas, F. Ann Hayes, A. A. Green	1987	64
16	Escalating systemic exposure of continuous infusion topotecan in children with recurrent acute leukemia. Journal of Clinical Oncology ·Wayne L. Furman, Sharyn D. Baker, C B Pratt, Gaston K. Rivera, William E. Evans, Clinton F. Stewart	1996	63
17	Malignant melanoma in children: Its management and prognosis Journal of Pediatric Surgery ·B. N. Rao, F. Ann Hayes, C B Pratt, Ingrid Fleming, Anant Kumar, Thom E. Lobe, Raza A. Dilawari, William H. Meyer, David M. Parham, Monford D. Custer	1990	61
18	Orbital development in long-term survivors of retinoblastoma. Journal of Clinical Oncology ·Sue C. Kaste, G Chen, James Fontanesi, Debbie Crom, C B Pratt	1997	60
19	Ifosfamide/Carboplatin/Etoposide (ICE) for Recurrent Malignant Solid Tumors of Childhood Journal of Pediatric Hematology/Oncology ·Faith Kung, Shaili Desai, Joseph D. Dickerman, Allen M. Goorin, M. Brennan Harris, Shuhei Inoue, Jeffrey P. Krischer, S Murphy, C B Pratt, Stuart Toledano, Joseph M. Wiley, Alice L. Yu	1995	46
20	Tumor size as a predictor of outcome in pediatric non‐metastatic osteosarcoma of the extremity Pediatric Blood & Cancer ·Sue C. Kaste, T. Liu, Catherine A. Billups, Najat C. Daw, C B Pratt, William H. Meyer	2004	43

About C B Pratt

C B Pratt is a scholar working on Neurology, Pathology and Forensic Medicine, Ophthalmology, Pulmonary and Respiratory Medicine and Hematology, having authored 65 papers that have together received 2.6k indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (16 papers), Sarcoma Diagnosis and Treatment (15 papers), Neuroblastoma Research and Treatments (13 papers), Chemotherapy-induced organ toxicity mitigation (7 papers), Glioma Diagnosis and Treatment (6 papers), Ocular Oncology and Treatments (6 papers), Cancer Treatment and Pharmacology (5 papers) and Testicular diseases and treatments (5 papers). The work is most often cited by research in Oncology (975 citations), Neurology (482 citations), Genetics (303 citations), Pathology and Forensic Medicine (476 citations) and Pulmonary and Respiratory Medicine (842 citations). C B Pratt has collaborated with scholars based in United States, Canada and Slovakia. Frequent co-authors include William H. Meyer, L. Kun, Sue C. Kaste, Marc E. Horowitz, Gaston K. Rivera, Clinton F. Stewart, Craig A. Hurwitz, M L Hancock, Melissa M. Hudson and Wayne L. Furman. Their work appears in journals such as Journal of Clinical Oncology, American Journal of Roentgenology, Cancer, Journal of Pediatric Surgery and JNCI Journal of the National Cancer Institute.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact